Disease | Source | Dose | Route | Mechanism of action | Side effects |
---|---|---|---|---|---|
Diabetic nephropathy | Mice bone marrow | 0.5 × 106 cells | Intravenous | Engraftment/direct effect | None |
Diabetic nephropathy | Human bone marrow | 2 × 106 cells | Intracardiac | Engraftment/direct effect | None |
Partial nephrectomy | Rat bone marrow | 1 × 106 cells | Intravenous | Paracrine effect | None |
Chronic allograft nephropathy | Rat bone marrow | 0.5 × 106 cells | Intravenous | Immunomodulatory effect | None |
Renal revascularization | Allogeneic swine adipose tissue | 10 × 106 cells | Intrarenal | Engraftment/direct effect/paracrine | None |
Renal artery stenosis | Autologous swine adipose tissue | 10 × 106 cells | Intrarenal | Engraftment/direct effect/paracrine | None |